SARAH DOBARD: Open Payments
NPI 1902583123 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$510 in 4 payments from 4 companies in 2025. Trend: 2023 $249 · 2024 $361 · 2025 $510
Food & beverage: $510
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 1 | $136 |
| Janssen Pharmaceuticals, Inc | 1 | $133 |
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $115 |
Products named: COBENFY, INVEGA SUSTENNA, UZEDY, Auvelity.
Industry payments across MO — which companies pay providers there.
